Market Tracker

02/22 3:50am ET

Vanguard Health Care Index Fund ETF Shares (VHT)

157.88
Delayed Data
As of Feb 21
 -0.45 / -0.28%
Today’s Change
135.40
Today|||52-Week Range
171.30
+2.43%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50- an index made up of stocks of large- mid-size- and small U.S. companies within the health care sector- as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all- or substantially all- of its assets in the stocks that make up the index- in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

No recent news for Vanguard Health Care Index Fund ETF Shares.

Performance

1 month-4.07% 3 years+7.23%
3 months+4.10% 5 years+16.72%
1 year+16.86% Since inception+9.90%
Data through 02/22/2018

Quote Details

Previous close$158.33
Open day’s range157.84 – 160.60
Net asset value (NAV)157.81 (02/21/2018)
Daily volume124,952
Average volume (3 months)232,936
Data as of 8:00pm ET, 02/21/2018

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+16.72%+17.28%
Expense Gross exp ratio0.10%1.31%
Risk 5 year sharpe ratio1.371.11
Net assets$8.7B$3.2B
Average market cap$57.9B$9.5B
Average P/E25.922.6
Dividend / Share--0.34%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.48%
UNH UnitedHealth5.85%
PFE Pfizer5.63%
ABBV AbbVie4.57%
MRK Merck4.13%
AMGN Amgen3.47%
MDT Medtronic PLC2.98%
GILD Gilead Sciences2.80%
ABT Abbott Laboratories2.76%
BMY Bristol-Myers Squibb2.62%